Select Page

Home / Share Price Target / Lincoln

Lincoln Pharmaceuticals Share Price Target 2024, 2025, 2026 to 2039 With Charts

Lincoln Pharmaceuticals Limited

Company LogoSymbol: LINCOLN
Price: ₹772.79
Exchange: NSE
Healthcare -> Drug Manufacturers—Specialty & Generic
Show Table of Contents

Lincoln Pharmaceuticals Brief Company Overview

Lincoln Pharmaceuticals Limited: A Renowned Pharmaceutical Manufacturer

Lincoln Pharmaceuticals Limited, established in 1979, is a leading pharmaceutical manufacturer based in India. The company has a strong global presence, providing a wide range of pharmaceutical products in various therapeutic areas.

Diverse Product Portfolio: Lincoln Pharmaceuticals boasts a comprehensive product range, including cough and cold medications, ophthalmic products, anti-malarial drugs, vitamins and minerals, anti-bacterial, anti-viral, and anti-fungal medications, analgesics, anti-psychotics, cardiovascular drugs, gastrointestinal products, and dermatological preparations. It also offers branded generics.

Commitment to Quality: Lincoln Pharmaceuticals is committed to providing high-quality pharmaceutical products. The company has a strong focus on research and development, ensuring its products meet the highest industry standards.

Reputation and Innovation: Over the years, Lincoln Pharmaceuticals has established a strong reputation in the pharmaceutical industry. The company is known for its innovation, quality standards, and commitment to patient health. It continues to explore new therapeutic areas and develop innovative products.


Advertisement

Lincoln Pharmaceuticals Financial Performance

MetricValueDescription
Market Capital1,548.09 CroreMarket valuation of Lincoln Pharmaceuticals's shares.
Revenue (TTM)592.21 CroreTotal revenue generated by Lincoln Pharmaceuticals over the past twelve months.
Net Income (TTM)+97.96 CroreNet Profit or Loss after all the expenses over the past twelve months.
Operating Margin13.24%Income from operations as a percentage of revenue, before taxes and interest.
Profit Margin16.54%Net income as a percentage of revenue, after all expenses.
Revenue Growth
(Quarterly)
+8.6%Change in revenue compared to the previous quarter.
Earnings Growth
(YOY Quarterly)
+24.5%Change in earnings compared to the same quarter last year.
Debt-to-Equity
(D/E) Ratio
0.18Company's total debt divided by total shareholder equity.
Total Debt1.06 CroreSum of Lincoln Pharmaceuticals's current & long-term financial obligations.
Total Cash152.74 CroreTotal amount of liquid funds available to Lincoln Pharmaceuticals.
Beta0.72Beta is less than 1 indicating that the Lincoln Pharmaceuticals's price is less volatile than the market.

Is Lincoln Pharmaceuticals A Good Buy For Long Term?

No valid response content found

To predict the Lincoln Pharmaceuticals's future market prices, we harnessed 2 dynamic approaches:

Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices

Approach 1: Technical Analysis Paired With Price Action

Lincoln Pharmaceuticals Share Price Target For 2024

Lincoln Pharmaceuticals Targets For 2024 Chart

The line chart displays the monthly closing prices of Lincoln Pharmaceuticals with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Lincoln Pharmaceuticals shares in 2024, see the table below.

Advertisement

Lincoln Pharmaceuticals Share Price Target Table For 2024

Lincoln Pharmaceuticals's LevelsValueReason/Importance
2024 Target 3823.91 (+6.61%)Price Action: Chart
2024 Target 2808.55 (+4.62%)Price Action: Chart
2024 Target 1800.54 (+3.59%)Fibonacci Extension Level 100%
Current Price772.79Lincoln Pharmaceuticals's 1 share price as of Fri 06 Sep 2024
Stop Loss 1755.90 (-2.19%)Price Action: Sep 2024 Low
Stop Loss 2744.94 (-3.61%)Fibonacci Retracement Level 38.2%
Stop Loss 3728.95 (-5.68%)Price Action: 23 Aug 2024 High

Summary: Lincoln Pharmaceuticals Share Price Prediction For 2024

In summary, Lincoln Pharmaceuticals has surged by ₹163.29, achieving a notable +26.79% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Lincoln Pharmaceuticals for 2024 predicts an additional rise of 3.59% to 6.61% by the end of 2024 with three potential targets T1: 800.54, T2: 808.55, T3: 823.91. Stop Loss at SL1: 755.90, SL2: 744.94, SL3: 728.95.

Lincoln Pharmaceuticals has a 52-week high of ₹803.29, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹472.00, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's share price prediction, let's now check what 2025 might hold for Lincoln Pharmaceuticals.

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Lincoln Pharmaceuticals Share Price Target For 2025

Lincoln Pharmaceuticals Targets For 2025 Chart

The line chart displays the monthly closing prices of Lincoln Pharmaceuticals with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.

For detailed target and stop loss values for Lincoln Pharmaceuticals shares in 2025, see the table below.

Advertisement

Lincoln Pharmaceuticals Share Price Target Table For 2025

Lincoln Pharmaceuticals's LevelsValueReason/Importance
2025 Target 31068.26 (+38.23%)Price Action: Chart
2025 Target 21048.34 (+35.65%)Price Action: Chart
2025 Target 11037.96 (+34.31%)Custom Fibonacci Extension Lvl 64.9%
Current Price772.79Lincoln Pharmaceuticals's 1 share price as of Fri 06 Sep 2024
Stop Loss 1711.59 (-7.92%)Price Action: 29 Aug 2024 High
Stop Loss 2702.90 (-9.05%)Price Action: 02 Sep 2024 Low
Stop Loss 3694.50 (-10.14%)Price Action: 08 Aug 2024 High

Summary: Lincoln Pharmaceuticals Share Price Prediction For 2025

In summary, Lincoln Pharmaceuticals has surged by ₹163.29, achieving a notable +26.79% increase from 1st January 2024 to 06 Sep 2024. Our analysis of Lincoln Pharmaceuticals for 2025 predicts an additional rise of 34.31% to 38.23% by the end of 2025 with three potential targets T1: 1037.96, T2: 1048.34, T3: 1068.26. Stop Loss at SL1: 711.59, SL2: 702.90, SL3: 694.50.

Lincoln Pharmaceuticals has a All-Time high of ₹804.45, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹472.00, a critical support level - think of this as a safety net where the price might stop falling.

After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Lincoln Pharmaceuticals, we have created a specific page for that check here: Lincoln Pharmaceuticals Share Price Target For Tomorrow & Next Week

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Approach 2: Machine Learning By Studying Historical Prices

Lincoln Pharmaceuticals Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039

Lincoln Pharmaceuticals Targets Chart 2024, 2025, 2026 to 2039

This chart presents a detailed projection of Lincoln Pharmaceuticals share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 12.24% over the next 15 years.

For complete year by year Lincoln Pharmaceuticals long term share price target from 2024, 2025 to 2039 check the below table.

Lincoln Pharmaceuticals Share Price Target Table From 2024, 2025, 2026 to 2039

YearLincoln Pharmaceuticals TargetYoY Change %
2024₹772.79[Current Price]
2024₹771.53-0.17%
2025₹984.0627.54%
2026₹1,201.7322.11%
2027₹1,466.9622.07%
2028₹1,574.897.35%
2029₹1,824.1915.82%
2030₹2,038.8511.76%
2031₹2,262.4610.96%
2032₹2,567.513.48%
2033₹2,602.251.35%
2034₹2,876.8510.55%
2035₹3,093.647.53%
2036₹3,323.187.41%
2037₹3,668.0510.37%
2038₹3,629.62-1.05%
2039₹3,884.747.02%

Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!

Join our WhatsApp group

Join our Telegram group

Your phone number will be HIDDEN to other users.

Lincoln Pharmaceuticals Past Performance

LINCOLN main
Lincoln Pharmaceuticals has been listed on NSE for more than 19 years.
  • In 2005, Lincoln Pharmaceuticals opening price was ₹44.2
  • As of Fri 06 Sep 2024 the price stands at ₹772.79.
  • This represents a Compound Annual Growth Rate (CAGR) of 15.38%.
  • In 19 years, an investment of 10,000 would have become ₹1.74 Lakh.

As we wrap up, we hope you like our study on Lincoln Pharmaceuticals share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.

Show Methodology We Use

Methodology Behind the Prediction

The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.

We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.

For more insights into Lincoln Pharmaceuticals Limited, explore these additional resources:-

Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.

About The Author

Nippun

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, and let’s learn from each other. My Twitter